Special Issue "Medication Use of Patients in hemodialysis patients"

A special issue of Pharmacy (ISSN 2226-4787).

Deadline for manuscript submissions: 31 July 2020.

Special Issue Editor

Prof. Dr. Marisa Battistella
Guest Editor
Department of Pharmacy-University Health Network- Leslie Dan Faculty of Pharmacy University of Toronto – Toronto Ontario Canada M4G 2C4
Interests: medication optimization in chronic kidney disease

Special Issue Information

Dear Colleagues,

Polypharmacy refers to the use of multiple concurrent medications, typically five or more per day. Consequences of polypharmacy can be numerous and drastic. These include adverse drug reactions, drug–drug interactions, non-adherence, increased risk of cognitive impairment, impaired balance, and falls; and finally, an increased risk of morbidity, hospitalization, and mortality by greater than 45%.2-Patients on hemodialysis (HD) have the highest pill burden of all chronically ill patient populations, taking on average 12 + 5 distinct medications per day.

We invite you to share your approaches and successes in understanding and improving medication use in patients on hemodialysis. We hope this Special Issue will inspire other clinicians to share their own practices, adopt new approaches, and innovate to help patients on hemodialysis manage their medications.

Prof. Dr. Marisa Battistella
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • medication use
  • medication optimization
  • deprescribing
  • chronic kidney disease
  • hemodialysis

Published Papers

This special issue is now open for submission.
Back to TopTop